Lunai Bioworks Inc. (LNAI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 15K 30K 45K Q4 '13: 32.8K Q4 '13

Gross Profit TTM

-300K -200K -100K 0 100K 200K 300K Q4 '13: -76.5K Q1 '14: -110.5K Q2 '14: -137.8K Q3 '14: -266K Q2 '15: -279.6K Q4 '13 Q1 '14 Q2 '14 Q3 '14 Q2 '15

Operating Income TTM

-210M -140M -70M 0 70M 140M 210M Q4 '13: -1.7M Q1 '14: -2M Q2 '14: -2.3M Q3 '14: -2.5M Q2 '15: -4.2M Q3 '15: -4M Q4 '15: -3.7M Q1 '16: -3.3M Q2 '16: -2.1M Q2 '17: -2.4M Q3 '17: -2.2M Q4 '17: -2.9M Q1 '18: -5.8M Q2 '18: -5.3M Q3 '18: -6.5M Q4 '18: -9.6M Q1 '19: -9.1M Q2 '19: -11M Q3 '19: -11.6M Q4 '19: -10.1M Q1 '20: -11.2M Q2 '20: -11.9M Q3 '20: -12.3M Q4 '20: -12.8M Q1 '21: -12.1M Q2 '21: -23.4M Q3 '21: -28M Q4 '21: -31.1M Q1 '22: -32.1M Q2 '22: -116.1M Q3 '22: -115.8M Q4 '22: -113.8M Q1 '23: -113.8M Q2 '23: -38.6M Q3 '23: -40.3M Q4 '23: -40.2M Q1 '24: -87.5M Q2 '24: -81.6M Q3 '24: -126.1M Q4 '24: -126.4M Q1 '25: -79.2M Q2 '25: -189M Q3 '25: -138.9M Q4 '25: -136.2M Q1 '26: -133.5M Q2 '14 Q2 '16 Q3 '18 Q1 '20 Q3 '21 Q1 '23 Q3 '24 Q1 '26

Net Income TTM

-210M -140M -70M 0 70M 140M 210M Q1 '12: -29.9K Q2 '12: -40.9K Q3 '12: -33.8K Q4 '12: -32.3K Q1 '13: -427K Q2 '13: -759.9K Q3 '13: -1.1M Q4 '13: -1.1M Q1 '14: -1.2M Q2 '14: -1.3M Q3 '14: -1.4M Q2 '15: -4.2M Q3 '15: -4M Q4 '15: -3.4M Q1 '16: -2.4M Q2 '16: -1.7M Q2 '17: -2.1M Q3 '17: -1.6M Q4 '17: -1.7M Q1 '18: -4.4M Q2 '18: -4.3M Q3 '18: -4.4M Q4 '18: -19.4M Q1 '19: -19.2M Q2 '20: -11.4M Q3 '20: -9.7M Q4 '20: -10.9M Q1 '21: -13.5M Q2 '21: -26.7M Q3 '21: -34.7M Q4 '21: -38.4M Q1 '22: -40.6M Q2 '22: -113.4M Q3 '22: -110.7M Q4 '22: -108.6M Q1 '23: -106.7M Q2 '23: -39.7M Q3 '23: -41.2M Q4 '23: -41.2M Q1 '24: -95.9M Q2 '24: -88.4M Q3 '24: -123.5M Q4 '24: -126.2M Q1 '25: -67M Q2 '25: -178M Q3 '25: -131M Q4 '25: -125.5M Q1 '26: -128.3M Q2 '13 Q2 '15 Q3 '17 Q1 '19 Q3 '21 Q1 '23 Q3 '24 Q1 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-27M -18M -9M 0 9M 18M 27M Q1 '12: -24.9K Q2 '12: -31.7K Q3 '12: -33.9K Q4 '12: -32.5K Q1 '13: -1.2M Q2 '13: -1.1M Q3 '13: -1.2M Q4 '13: -1.2M Q1 '14: -471.3K Q2 '14: -668.5K Q3 '14: -1.1M Q4 '14: -2M Q1 '15: -3.6M Q2 '15: -5.2M Q3 '15: -5.2M Q4 '15: -4.9M Q1 '16: -2.9M Q2 '16: -1.5M Q4 '17: -1.5M Q1 '18: -3.2M Q2 '18: -4.3M Q3 '18: -5.6M Q4 '18: -6.9M Q1 '19: -7.9M Q2 '19: -8.5M Q3 '19: -8.5M Q4 '19: -9.3M Q1 '20: -10.4M Q2 '20: -10.5M Q3 '20: -11.4M Q4 '20: -11.3M Q1 '21: -9.8M Q2 '21: -20.6M Q3 '21: -23.1M Q4 '21: -25.3M Q1 '22: -25.7M Q2 '22: -15.7M Q3 '22: -13.1M Q4 '22: -12M Q1 '23: -12.6M Q2 '23: -11.8M Q3 '23: -11.9M Q4 '23: -11.5M Q1 '24: -10.8M Q2 '24: -11M Q3 '24: -10.2M Q4 '24: -9.6M Q1 '25: -8.5M Q2 '25: -7.9M Q3 '25: -7.2M Q4 '25: -5.7M Q1 '26: -5.3M Q3 '12 Q2 '14 Q1 '16 Q1 '19 Q4 '20 Q3 '22 Q2 '24 Q1 '26

Free Cash Flow TTM

-27M -18M -9M 0 9M 18M 27M Q1 '19: -8.6M Q2 '19: -9.2M Q3 '19: -9M Q4 '19: -9.5M Q1 '20: -10.6M Q2 '20: -10.6M Q3 '20: -11.5M Q4 '20: -11.4M Q1 '21: -9.8M Q2 '21: -20.7M Q3 '21: -23.2M Q4 '21: -25.3M Q1 '22: -25.8M Q2 '22: -15.7M Q2 '19 Q4 '19 Q2 '20 Q4 '20 Q2 '21 Q4 '21 Q2 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q1 '14: 6.9M Q3 '14: 8.1M Q4 '14: 8.9M Q1 '15: 9.5M Q3 '15: 9.5M Q4 '15: 9.5M Q1 '16: 9.5M Q3 '16: 9.5M Q4 '16: 9.5M Q1 '17: 9.5M Q3 '22: 55.1M Q4 '22: 55.5M Q1 '23: 56M Q3 '23: 64.5M Q4 '23: 65.9M Q1 '24: 109.2M Q3 '24: 16M Q4 '24: 16.2M Q1 '25: 16.4M Q3 '25: 22.5M Q4 '25: 23.5M Q1 '26: 25M Q1 '14 Q1 '15 Q1 '16 Q1 '17 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '13: -0.40 Q1 '14: -0.38 Q2 '14: -0.38 Q3 '14: -0.38 Q2 '15: -0.46 Q3 '15: -0.43 Q4 '15: -0.36 Q1 '16: -0.25 Q2 '16: -0.18 Q2 '18: -0.26 Q3 '18: -0.25 Q4 '18: -0.62 Q1 '19: -0.57 Q2 '20: -0.25 Q3 '20: -0.21 Q4 '20: -0.23 Q1 '21: -0.29 Q2 '21: -0.57 Q3 '21: -0.72 Q4 '21: -0.79 Q2 '23: -0.71 Q3 '23: -0.71 Q4 '23: -0.70 Q1 '24: -1.16 Q2 '24: -0.75 Q3 '24: -3.37 Q4 '24: -3.75 Q1 '25: -3.21 Q3 '14 Q1 '16 Q4 '18 Q4 '20 Q4 '21 Q1 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.